These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 29157801)

  • 1. Corrigendum to "Structure and pharmaceutical formulation development of a new long-acting recombinant human insulin analog studied by NMR and MS" [J. Pharm. Biomed. Anal. 135 (2017) 126-132].
    Bednarek E; Sitkowski J; Bocian W; Borowicz P; Płucienniczak G; Stadnik D; Surmacz-Chwedoruk W; Jaworska B; Kozerski L
    J Pharm Biomed Anal; 2018 Jan; 148():380. PubMed ID: 29157801
    [No Abstract]   [Full Text] [Related]  

  • 2. Structure and pharmaceutical formulation development of a new long-acting recombinant human insulin analog studied by NMR and MS.
    Bednarek E; Sitkowski J; Bocian W; Borowicz P; Płucienniczak G; Stadnik D; Surmacz-Chwedoruk W; Jaworska B; Kozerski L
    J Pharm Biomed Anal; 2017 Feb; 135():126-132. PubMed ID: 28024260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corrigendum to "Ceftriaxone pharmacokinetics by a sensitive and simple LC-MS/MS method: Development and application" [J. Pharm. Biomed. Anal. 189 (2020) 113484].
    Herrera-Hidalgo L; Gil-Navarro MV; Dilly Penchala S; López-Cortes LE; de Alarcón A; Luque-Márquez R; López-Cortes LF; Gutiérrez-Valencia A
    J Pharm Biomed Anal; 2021 Jul; 201():114098. PubMed ID: 33933703
    [No Abstract]   [Full Text] [Related]  

  • 4. Corrigendum to "A validated UHPLC-MS/MS method for simultaneous quantification of 9 exocyclic DNA adducts induced by 8 aldehydes" [J. Pharm. Biomed. Anal. 179 (2020) Article Number 1499].
    Alamil H; Lechevrel M; Lagadu S; Galanti L; Dagher Z; Delépée R
    J Pharm Biomed Anal; 2020 Jun; 185():113248. PubMed ID: 32276748
    [No Abstract]   [Full Text] [Related]  

  • 5. Corrigendum to "LC-MS/MS method for the simultaneous analysis of seven antimalarials and two active metabolites in dried blood spots for applications in field trials: Analytical and clinical validation" [J. Pharm. Biomed. Anal. 154 (2018) 263-277].
    Gallay J; Prod'hom S; Mercier T; Bardinet C; Spaggiari D; Pothin E; Buclin T; Genton B; Decosterd LA
    J Pharm Biomed Anal; 2020 Apr; 182():112759. PubMed ID: 32063409
    [No Abstract]   [Full Text] [Related]  

  • 6. Corrigendum to "Genetic and protein biomarkers in blood for the improved detection of GH abuse" [J. Pharm. Biomed. Anal. 128 (2016) 111-118, doi: 10.1016/j.jpba.2016.05.022.].
    Ferro P; Ventura R; Pérez-Mañá C; Farré M; Segura J
    J Pharm Biomed Anal; 2017 Feb; 134():385. PubMed ID: 27876384
    [No Abstract]   [Full Text] [Related]  

  • 7. Corrigendum to "Characterizing metabolites and potential metabolic pathways changes to understanding the mechanism of medicinal plant against doxorubicin-indu Phellodendri amurensis cortexced nephritis rats using UPLC-Q/TOF-MS metabolomics" [J. Pharm. Biomed. Anal. 188 (2020) 1-14/11336].
    Zhang H; Zhang S; Wang W; Wang Q; Kuang H; Wang Q
    J Pharm Biomed Anal; 2020 Nov; 191():113608. PubMed ID: 32919142
    [No Abstract]   [Full Text] [Related]  

  • 8. Corrigendum to "Quantification of diterpene acids in Copaiba oleoresin by UHPLC-ELSD and heteronuclear two-dimensional qNMR" [J. Pharm. Biomed. Anal. 160 (2018) 126-134].
    Çiçek SS; Barbosa ALP; Girreser U
    J Pharm Biomed Anal; 2019 Mar; 166():440. PubMed ID: 30635137
    [No Abstract]   [Full Text] [Related]  

  • 9. Corrigendum to "Comparative tissue distribution and excretion study of alkaloids from Herba Ephedrae-Radix Aconiti Lateralis extracts in rats" [J. Pharm. Biomed. Anal., 134 (2017) 137-142].
    Ren M; Song S; Liang D; Hou W; Tan X; Luo J
    J Pharm Biomed Anal; 2017 Jun; 140():392. PubMed ID: 28433183
    [No Abstract]   [Full Text] [Related]  

  • 10. Corrigendum to "Surface plasmon resonance and circular dichroism characterization of cucurbitacins binding to serum albumins for early pharmacokinetic profiling" [J. Pharm. Biomed. Anal. 122 (2016) 166-172].
    Fabini E; Fiori GM; Tedesco D; Lopes NP; Bertucci C
    J Pharm Biomed Anal; 2016 Jun; 125():433. PubMed ID: 27066735
    [No Abstract]   [Full Text] [Related]  

  • 11. Corrigendum to "Application of Analytical Quality by Design concept for bilastine and its degradation impurities determination by hydrophilic interaction liquid chromatographic method" [J. Pharm. Biomed. Anal. 125 (2016) 385-393].
    Terzić J; Popović I; Tumpa A; Stajić A; Jančić-Stojanović B
    J Pharm Biomed Anal; 2017 May; 138():386. PubMed ID: 28249713
    [No Abstract]   [Full Text] [Related]  

  • 12. Corrigendum to "Design and validation of an automated solid phase extraction liquid chromatography coupled mass spectrometry method for the quantification of propofol in plasma" [J. Pharm. Biomed. Anal. 150 (2018) 341-346].
    Maurer F; Shopova T; Wolf B; Kiefer D; Hüppe T; Volk T; Sessler DI; Kreuer S
    J Pharm Biomed Anal; 2018 Apr; 152():322. PubMed ID: 29501126
    [No Abstract]   [Full Text] [Related]  

  • 13. Corrigendum to "Drug-protein binding mechanism of juglone for early pharmacokinetic profiling: Insights from ultrafiltration, multi-spectroscopic and molecular docking methods" [J. Pharm. Biomed. Anal., 141 (2017) 262-269].
    Zhao P; Gao G; Zhang L; Cai Q; Lu N; Cheng L; Li S; Hou X
    J Pharm Biomed Anal; 2017 Sep; 143():311. PubMed ID: 28668153
    [No Abstract]   [Full Text] [Related]  

  • 14. Corrigendum to "Comprehensive metabolic profiles of seminal plasma with different forms of male infertility and their correlation with sperm parameters'' [J. Pharm. Biomed. Anal. 177 (2020) 112888 / UNSP 112888].
    Xu Y; Lu H; Wang Y; Zhang Z; Wu Q
    J Pharm Biomed Anal; 2020 May; 184():113167. PubMed ID: 32192798
    [No Abstract]   [Full Text] [Related]  

  • 15. Corrigendum to "Therapeutic application of cannabidiol on UVA and UVB irradiated rat skin. A proteomic study" [J. Pharm. Biomed. Anal. 192 (2021) 1-9/113656].
    Atalay S; Gęgotek A; Wroński A; Domigues P; Skrzydlewska E
    J Pharm Biomed Anal; 2021 Jun; 200():114038. PubMed ID: 33887671
    [No Abstract]   [Full Text] [Related]  

  • 16. Corrigendum to "A high-performance liquid chromatography-tandem mass spectrometry method for the analysis of lifirafenib, a novel RAF kinase and EGFR inhibitor, in human plasma and urine, and its application in a clinical pharmacokinetic study" [J. Pharm. Biomed. Anal. 166 (2019) 20-29].
    Yao X; Song L; Liu Y; Wang H; Liu J; Jiang J; Liu D; Hu P
    J Pharm Biomed Anal; 2020 Mar; 181():112627. PubMed ID: 31255416
    [No Abstract]   [Full Text] [Related]  

  • 17. Corrigendum to "Pt-Pd-doped NiO nanoparticle decorated at single-wall carbon nanotubes: An excellent, powerful electrocatalyst for the fabrication of an electrochemical sensor to determine nalbuphine in the presence of tramadol as two opioid analgesic drugs" [J. Pharm. Biomed. Anal. 189 (2020) 113397].
    Tavana T; Rezvani AR; Karimi-Maleh H
    J Pharm Biomed Anal; 2021 May; 199():114030. PubMed ID: 33774458
    [No Abstract]   [Full Text] [Related]  

  • 18. Corrigendum to "Development and validation of LC-MS/MS assays for the quantification of bendamustine and its metabolites in human plasma and urine" [J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 893-894 (2012) 92-100].
    Dubbelman AC; Tibben M; Rosing H; Gebretensae A; Nan L; Gorman SH; Robertson P; Schellens JH; Beijnen JH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 May; 1020():168-9. PubMed ID: 27063483
    [No Abstract]   [Full Text] [Related]  

  • 19. Erratum to "Absorption, liver first-pass effect, pharmacokinetics and tissue distribution of calycosin-7-O-ß-d-glucopyranoside (C7G) and its major active metabolite, calycosin, following oral administration of C7G in rats by LC-MS/MS" [J. Pharm. Biomed. Anal. 148 (2018) 350-354].
    Tian X; Chen S; Zhang Y; Chen L; Guo X; Xu Z; Liu H; Hu P; Chen Z; Li Z; Huang C
    J Pharm Biomed Anal; 2018 Feb; 150():474. PubMed ID: 29329769
    [No Abstract]   [Full Text] [Related]  

  • 20. Structure of the major degradant of ezetimibe.
    Sánta Z; Kóti J; Szoke K; Vukics K; Szántay C
    J Pharm Biomed Anal; 2012 Jan; 58():125-9. PubMed ID: 21978828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.